WATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 20, 2005--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC) ("Panacos" or "the Company"), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its third quarter 2005 financial results after the U.S. Financial Markets close on Thursday, October 27, 2005. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company's development programs. Dr. Samuel K. Ackerman, President and CEO, will lead the call.
